Human Gene EPHA2 (ENST00000358432.8_7) from GENCODE V47lift37
  Description: EPH receptor A2, transcript variant 1 (from RefSeq NM_004431.5)
Gencode Transcript: ENST00000358432.8_7
Gencode Gene: ENSG00000142627.13_9
Transcript (Including UTRs)
   Position: hg19 chr1:16,450,832-16,482,564 Size: 31,733 Total Exon Count: 17 Strand: -
Coding Region
   Position: hg19 chr1:16,451,710-16,482,427 Size: 30,718 Coding Exon Count: 17 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr1:16,450,832-16,482,564)mRNA (may differ from genome)Protein (976 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMalacardsMGIOMIMPubMedReactome
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: EPHA2_HUMAN
DESCRIPTION: RecName: Full=Ephrin type-A receptor 2; EC=2.7.10.1; AltName: Full=Epithelial cell kinase; AltName: Full=Tyrosine-protein kinase receptor ECK; Flags: Precursor;
FUNCTION: Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation of cells. Regulates cell adhesion and differentiation through DSG1/desmoglein-1 and inhibition of the ERK1/ERK2 (MAPK3/MAPK1, respectively) signaling pathway. May also participate in UV radiation-induced apoptosis and have a ligand- independent stimulatory effect on chemotactic cell migration. During development, may function in distinctive aspects of pattern formation and subsequently in development of several fetal tissues. Involved for instance in angiogenesis, in early hindbrain development and epithelial proliferation and branching morphogenesis during mammary gland development. Engaged by the ligand ephrin-A5/EFNA5 may regulate lens fiber cells shape and interactions and be important for lens transparency development and maintenance. With ephrin-A2/EFNA2 may play a role in bone remodeling through regulation of osteoclastogenesis and osteoblastogenesis.
CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.
SUBUNIT: Homodimer. Interacts with SLA. Interacts (phosphorylated form) with VAV2, VAV3 and PI3-kinase p85 subunit (PIK3R1, PIK3R2 or PIK3R3); critical for the EFNA1-induced activation of RAC1 which stimulates cell migration. Interacts with ANKS1A (By similarity). Interacts with INPPL1; regulates activated EPHA2 endocytosis and degradation. Interacts (inactivated form) with PTK2/FAK1 and interacts (EFNA1 ligand-activated form) with PTPN11; regulates integrin-mediated adhesion. Interacts with ARHGEF16, DOCK4 and ELMO2; mediates ligand-independent activation of RAC1 which stimulates cell migration. Interacts with CLDN4; phosphorylates CLDN4 and may regulate tight junctions. Interacts with ACP1.
INTERACTION: P20827:EFNA1; NbExp=5; IntAct=EBI-702104, EBI-715194; Q15375:EPHA7; NbExp=3; IntAct=EBI-702104, EBI-1383428; Q05397:PTK2; NbExp=3; IntAct=EBI-702104, EBI-702142;
SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein. Cell projection, ruffle membrane; Single-pass type I membrane protein. Cell projection, lamellipodium membrane; Single- pass type I membrane protein. Cell junction, focal adhesion. Note=Present at regions of cell-cell contacts but also at the leading edge of migrating cells.
TISSUE SPECIFICITY: Expressed in brain and glioma tissue and glioma cell lines (at protein level). Expressed most highly in tissues that contain a high proportion of epithelial cells, e.g. skin, intestine, lung, and ovary.
INDUCTION: Up-regulated by UV irradiation via a TP53-independent, MAPK-dependent mechanism.
PTM: Autophosphorylates. Phosphorylated on tyrosine upon binding and activation by EFNA1. Phosphorylated residues Tyr-588 and Tyr- 594 are required for binding VAV2 and VAV3 while phosphorylated residues Tyr-735 and Tyr-930 are required for binding PI3-kinase p85 subunit (PIK3R1, PIK3R2 or PIK3R3). These phosphorylated residues are critical for recruitment of VAV2 and VAV3 and PI3- kinase p85 subunit which transduce downstream signaling to activate RAC1 GTPase and cell migration (By similarity). Phosphorylated at Ser-897 by PKB; serum-induced phosphorylation which targets EPHA2 to the cell leading edge and stimulates cell migration. Phosphorylation by PKB is inhibited by EFNA1-activated EPHA2 which regulates PKB activity via a reciprocal regulatory loop. Dephosphorylated by ACP1.
PTM: Ubiquitinated by CHIP/STUB1. Ubiquitination is regulated by the HSP90 chaperone and regulates the receptor stability and activity through proteasomal degradation. ANKS1A prevents ubiquitination and degradation (By similarity).
DISEASE: Genetic variations in EPHA2 are the cause of susceptibility to cataract cortical age-related type 2 (ARCC2) [MIM:613020]. A developmental punctate opacity common in the cortex and present in most lenses. The cataract is white or cerulean, increases in number with age, but rarely affects vision.
DISEASE: Defects in EPHA2 are the cause of cataract posterior polar type 1 (CTPP1) [MIM:116600]. A subcapsular opacity, usually disk-shaped, located at the back of the lens. It can have a marked effect on visual acuity.
DISEASE: Note=Overexpressed in several cancer types and promotes malignancy.
SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein kinase family. Ephrin receptor subfamily.
SIMILARITY: Contains 1 Eph LBD (Eph ligand-binding) domain.
SIMILARITY: Contains 2 fibronectin type-III domains.
SIMILARITY: Contains 1 protein kinase domain.
SIMILARITY: Contains 1 SAM (sterile alpha motif) domain.

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: EPHA2
Diseases sorted by gene-association score: cataract 6, multiple types* (1330), cataract 16, multiple types* (247), early-onset posterior subcapsular cataract* (202), early-onset nuclear cataract* (202), cataract 44* (94), pulmonary artery leiomyosarcoma (15), cataract (12), adenocarcinoma (6), tonsil cancer (6), disuse amblyopia (6), ovarian cancer, somatic (3), hepatitis c virus (3), melanoma (3), colorectal cancer (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene
  • D001564 Benzo(a)pyrene
  • D003993 Dibutyl Phthalate
  • D004997 Ethinyl Estradiol
  • D013749 Tetrachlorodibenzodioxin
  • D015058 1-Naphthylisothiocyanate
  • C014211 2,3,7,8-tetrachlorodibenzofuran
  • C548651 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester
  • C026137 3-hydroxyacetanilide
  • D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide
  • C545373 AP24534
          more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 84.66 RPKM in Esophagus - Mucosa
Total median expression: 441.17 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -54.80137-0.400 Picture PostScript Text
3' UTR -308.20878-0.351 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR001090 - Ephrin_rcpt_lig-bd_dom
IPR003961 - Fibronectin_type3
IPR008979 - Galactose-bd-like
IPR009030 - Growth_fac_rcpt
IPR013783 - Ig-like_fold
IPR011009 - Kinase-like_dom
IPR000719 - Prot_kinase_cat_dom
IPR017441 - Protein_kinase_ATP_BS
IPR001660 - SAM
IPR013761 - SAM/pointed
IPR021129 - SAM_type1
IPR001245 - Ser-Thr/Tyr_kinase_cat_dom
IPR008266 - Tyr_kinase_AS
IPR020635 - Tyr_kinase_cat_dom
IPR016257 - Tyr_kinase_ephrin_rcpt
IPR001426 - Tyr_kinase_rcpt_V_CS

Pfam Domains:
PF00041 - Fibronectin type III domain
PF00069 - Protein kinase domain
PF00536 - SAM domain (Sterile alpha motif)
PF01404 - Ephrin receptor ligand binding domain
PF07647 - SAM domain (Sterile alpha motif)
PF07714 - Protein tyrosine and serine/threonine kinase
PF09294 - Interferon-alpha/beta receptor, fibronectin type III
PF14575 - Ephrin type-A receptor 2 transmembrane domain

SCOP Domains:
47769 - SAM/Pointed domain
49363 - Purple acid phosphatase, N-terminal domain
49265 - Fibronectin type III
49785 - Galactose-binding domain-like
51905 - FAD/NAD(P)-binding domain
51971 - Nucleotide-binding domain
56112 - Protein kinase-like (PK-like)
57184 - Growth factor receptor domain

Protein Data Bank (PDB) 3-D Structure
MuPIT help
1MQB - X-ray MuPIT 2E8N - NMR MuPIT 2K9Y - NMR MuPIT 2KSO - NMR MuPIT 2X10 - X-ray MuPIT 2X11 - X-ray MuPIT 3C8X - X-ray MuPIT 3CZU - X-ray MuPIT 3FL7 - X-ray MuPIT 3HEI - X-ray MuPIT 3HPN - X-ray MuPIT 3KKA - X-ray MuPIT 3MBW - X-ray MuPIT 3MX0 - X-ray MuPIT 3SKJ - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on P29317
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGDEnsembl   
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0000166 nucleotide binding
GO:0001618 virus receptor activity
GO:0004672 protein kinase activity
GO:0004713 protein tyrosine kinase activity
GO:0004714 transmembrane receptor protein tyrosine kinase activity
GO:0005003 ephrin receptor activity
GO:0005515 protein binding
GO:0005524 ATP binding
GO:0016301 kinase activity
GO:0016740 transferase activity
GO:0045296 cadherin binding

Biological Process:
GO:0001525 angiogenesis
GO:0001649 osteoblast differentiation
GO:0006468 protein phosphorylation
GO:0006915 apoptotic process
GO:0007155 cell adhesion
GO:0007169 transmembrane receptor protein tyrosine kinase signaling pathway
GO:0007275 multicellular organism development
GO:0008630 intrinsic apoptotic signaling pathway in response to DNA damage
GO:0010591 regulation of lamellipodium assembly
GO:0016032 viral process
GO:0016310 phosphorylation
GO:0016477 cell migration
GO:0018108 peptidyl-tyrosine phosphorylation
GO:0030154 cell differentiation
GO:0030216 keratinocyte differentiation
GO:0030316 osteoclast differentiation
GO:0033598 mammary gland epithelial cell proliferation
GO:0033628 regulation of cell adhesion mediated by integrin
GO:0043491 protein kinase B signaling
GO:0043535 regulation of blood vessel endothelial cell migration
GO:0045765 regulation of angiogenesis
GO:0046058 cAMP metabolic process
GO:0046718 viral entry into host cell
GO:0046849 bone remodeling
GO:0048013 ephrin receptor signaling pathway
GO:0048870 cell motility
GO:0051898 negative regulation of protein kinase B signaling
GO:0060326 cell chemotaxis
GO:0060444 branching involved in mammary gland duct morphogenesis
GO:0070309 lens fiber cell morphogenesis
GO:0070372 regulation of ERK1 and ERK2 cascade
GO:0070848 response to growth factor
GO:0090630 activation of GTPase activity
GO:1903078 positive regulation of protein localization to plasma membrane

Cellular Component:
GO:0005622 intracellular
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0005925 focal adhesion
GO:0009986 cell surface
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0030027 lamellipodium
GO:0030054 cell junction
GO:0031256 leading edge membrane
GO:0031258 lamellipodium membrane
GO:0032587 ruffle membrane
GO:0042995 cell projection


-  Descriptions from all associated GenBank mRNAs
  BC008655 - Homo sapiens EPH receptor A2, mRNA (cDNA clone IMAGE:3852708), partial cds.
LP882418 - Sequence 13 from Patent WO2017180581.
M59371 - Human protein tyrosine kinase mRNA, complete cds.
BC037166 - Homo sapiens EPH receptor A2, mRNA (cDNA clone MGC:29717 IMAGE:5090654), complete cds.
JD222360 - Sequence 203384 from Patent EP1572962.
JD306585 - Sequence 287609 from Patent EP1572962.
JD158687 - Sequence 139711 from Patent EP1572962.
JD133964 - Sequence 114988 from Patent EP1572962.
JD257127 - Sequence 238151 from Patent EP1572962.
JD190866 - Sequence 171890 from Patent EP1572962.
JD224505 - Sequence 205529 from Patent EP1572962.
JD052616 - Sequence 33640 from Patent EP1572962.
AK296788 - Homo sapiens cDNA FLJ51229 complete cds, highly similar to Ephrin type-A receptor 2 precursor (EC 2.7.10.1).
JD341133 - Sequence 322157 from Patent EP1572962.
JD128576 - Sequence 109600 from Patent EP1572962.
JD441638 - Sequence 422662 from Patent EP1572962.
JD133692 - Sequence 114716 from Patent EP1572962.
JD253339 - Sequence 234363 from Patent EP1572962.
JD415936 - Sequence 396960 from Patent EP1572962.
JD146574 - Sequence 127598 from Patent EP1572962.
JD061245 - Sequence 42269 from Patent EP1572962.
DQ895231 - Synthetic construct Homo sapiens clone IMAGE:100009691; FLH182579.01L; RZPDo839H09137D EPH receptor A2 (EPHA2) gene, encodes complete protein.
EU176326 - Synthetic construct Homo sapiens clone IMAGE:100006424; FLH182586.01X; RZPDo839A07251D EPH receptor A2 (EPHA2) gene, encodes complete protein.
EU826606 - Homo sapiens soluble EPHA2 variant 1 (EPHA2) mRNA, complete cds, alternatively spliced.
LY623324 - KR 1020180134347-A/13: DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER.
MB416867 - JP 2019518426-A/7: DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein P29317 (Reactome details) participates in the following event(s):

R-HSA-3928646 EPHAs bind EFNAs
R-HSA-3928597 EPH:EFN dimers tetramerise
R-HSA-2682334 EPH-Ephrin signaling
R-HSA-3928665 EPH-ephrin mediated repulsion of cells
R-HSA-422475 Axon guidance
R-HSA-1266738 Developmental Biology

-  Other Names for This Gene
  Alternate Gene Symbols: B5A968, ECK, ENST00000358432.1, ENST00000358432.2, ENST00000358432.3, ENST00000358432.4, ENST00000358432.5, ENST00000358432.6, ENST00000358432.7, EPHA2_HUMAN, NM_004431, P29317, Q8N3Z2, uc318aoa.1, uc318aoa.2
UCSC ID: ENST00000358432.8_7
RefSeq Accession: NM_004431.5
Protein: P29317 (aka EPHA2_HUMAN)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.